SCHEMBL7873765

SCHEMBL7873765

CN(C)Cc1ccc(COc2cccc3cc(C(=O)N(C)C(=N)N)[nH]c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
TP53 P04637 3/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
SRD5A2 P31213 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
FLT3 P36888 1/20 0.36
SRD5A1 P18405 1/20 0.36
IDO1 P14902 1/20 0.36
PARP1 P09874 1/20 0.35
F2 P00734 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.34
HRH4 Q9H3N8 1/20 0.34
ATM Q13315 1/20 0.34
MGMT P16455 1/20 0.34
TNKS O95271 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880985 0.93 MGMT (0.42) MAPTTP53LMNARXFP1FLT3
SCHEMBL7873718 0.92 CFD (0.38) MAPTTP53ALDH1A1GAASRD5A2
SCHEMBL7873850 0.91 MAPT (0.39) MAPTTP53LMNAALDH1A1GAA
Hydrochloric Acid SCHEMBL7877859 0.90 SRD5A2 (0.42) MAPTTP53LMNASRD5A2RXFP1
SCHEMBL7880200 0.88 RXFP1 (0.38) MAPTTP53LMNARXFP1FLT3
SCHEMBL7877457 0.87 MEN1 (0.39) MAPTTP53LMNAALDH1A1RXFP1
SCHEMBL7877636 0.86 CFD (0.43) MAPTTP53LMNASRD5A2RXFP1
SCHEMBL7881382 0.85 AR (0.40) MAPTTP53LMNAALDH1A1GAA
SCHEMBL7879978 0.85 FLT3 (0.35) MAPTTP53LMNAALDH1A1RXFP1
SCHEMBL7882405 0.85 GYS1 (0.39) MAPTTP53LMNARXFP1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed